Copyright Reports & Markets. All rights reserved.

Global Angioplasty Balloons Market Report 2018-2029

Buy now

1 Industry Overview of Angioplasty Balloons

  • 1.1 Research Scope
  • 1.2 Market Segmentation by Types of Angioplasty Balloons
  • 1.3 Market Segmentation by End Users of Angioplasty Balloons
  • 1.4 Market Dynamics Analysis of Angioplasty Balloons
    • 1.4.1 Market Drivers
    • 1.4.2 Market Challenges
    • 1.4.3 Market Opportunities
    • 1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Angioplasty Balloons Industry

  • 2.1 Abbott Laboratories
    • 2.1.1 Company Overview
    • 2.1.2 Main Products and Specifications
    • 2.1.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.1.4 Contact Information
  • 2.2 Boston Scientific
    • 2.2.1 Company Overview
    • 2.2.2 Main Products and Specifications
    • 2.2.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.2.4 Contact Information
  • 2.3 C. R. Bard
    • 2.3.1 Company Overview
    • 2.3.2 Main Products and Specifications
    • 2.3.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.3.4 Contact Information
  • 2.4 Medtronic
    • 2.4.1 Company Overview
    • 2.4.2 Main Products and Specifications
    • 2.4.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.4.4 Contact Information
  • 2.5 Aachen Resonance
    • 2.5.1 Company Overview
    • 2.5.2 Main Products and Specifications
    • 2.5.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.5.4 Contact Information
  • 2.6 Acrostak
    • 2.6.1 Company Overview
    • 2.6.2 Main Products and Specifications
    • 2.6.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.6.4 Contact Information
  • 2.7 AMG International
    • 2.7.1 Company Overview
    • 2.7.2 Main Products and Specifications
    • 2.7.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.7.4 Contact Information
  • 2.8 Angioslide
    • 2.8.1 Company Overview
    • 2.8.2 Main Products and Specifications
    • 2.8.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.8.4 Contact Information
  • 2.9 Arthesys
    • 2.9.1 Company Overview
    • 2.9.2 Main Products and Specifications
    • 2.9.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.9.4 Contact Information
  • 2.10 Asahi Intecc
    • 2.10.1 Company Overview
    • 2.10.2 Main Products and Specifications
    • 2.10.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.10.4 Contact Information
  • 2.11 Atrium Medical
    • 2.11.1 Company Overview
    • 2.11.2 Main Products and Specifications
    • 2.11.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.11.4 Contact Information
  • 2.12 BrosMed
    • 2.12.1 Company Overview
    • 2.12.2 Main Products and Specifications
    • 2.12.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.12.4 Contact Information
  • 2.13 Cook Medical
    • 2.13.1 Company Overview
    • 2.13.2 Main Products and Specifications
    • 2.13.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.13.4 Contact Information
  • 2.14 Gadelius Medical
    • 2.14.1 Company Overview
    • 2.14.2 Main Products and Specifications
    • 2.14.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.14.4 Contact Information
  • 2.15 Lepu Medical
    • 2.15.1 Company Overview
    • 2.15.2 Main Products and Specifications
    • 2.15.3 Angioplasty Balloons Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.15.4 Contact Information

3 Global Angioplasty Balloons Market Analysis by Regions, Manufacturers, Types and End Users

  • 3.1 Global Sales Volume and Revenue of Angioplasty Balloons by Regions (2018-2023)
  • 3.2 Global Sales Volume and Revenue of Angioplasty Balloons by Manufacturers (2018-2023)
  • 3.3 Global Sales Volume and Revenue of Angioplasty Balloons by Types (2018-2023)
  • 3.4 Global Sales Volume and Revenue of Angioplasty Balloons by End Users (2018-2023)
  • 3.5 Selling Price Analysis of Angioplasty Balloons by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Angioplasty Balloons Market Analysis by Countries, Types and End Users

  • 4.1 Northern America Angioplasty Balloons Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 4.2 Northern America Angioplasty Balloons Sales Volume and Revenue Analysis by Types (2018-2023)
  • 4.3 Northern America Angioplasty Balloons Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 4.4 United States Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 4.5 Canada Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Angioplasty Balloons Market Analysis by Countries, Types and End Users

  • 5.1 Europe Angioplasty Balloons Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 5.2 Europe Angioplasty Balloons Sales Volume and Revenue Analysis by Types (2018-2023)
  • 5.3 Europe Angioplasty Balloons Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 5.4 Germany Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.5 France Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.6 UK Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.7 Italy Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.8 Russia Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.9 Spain Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.10 Netherlands Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Angioplasty Balloons Market Analysis by Countries, Types and End Users

  • 6.1 Asia Pacific Angioplasty Balloons Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 6.2 Asia Pacific Angioplasty Balloons Sales Volume and Revenue Analysis by Types (2018-2023)
  • 6.3 Asia Pacific Angioplasty Balloons Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 6.4 China Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.5 Japan Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.6 Korea Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.7 India Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.8 Australia Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.9 Indonesia Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.10 Vietnam Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Angioplasty Balloons Market Analysis by Countries, Types and End Users

  • 7.1 Latin America Angioplasty Balloons Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 7.2 Latin America Angioplasty Balloons Sales Volume and Revenue Analysis by Types (2018-2023)
  • 7.3 Latin America Angioplasty Balloons Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 7.4 Brazil Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.5 Mexico Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.6 Argentina Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.7 Colombia Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Angioplasty Balloons Market Analysis by Countries, Types and End Users

  • 8.1 Middle East & Africa Angioplasty Balloons Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 8.2 Middle East & Africa Angioplasty Balloons Sales Volume and Revenue Analysis by Types (2018-2023)
  • 8.3 Middle East & Africa Angioplasty Balloons Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 8.4 Turkey Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.5 Saudi Arabia Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.6 South Africa Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.7 Egypt Angioplasty Balloons Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis

  • 9.1 Marketing Channel
    • 9.1.1 Direct Channel
    • 9.1.2 Indirect Channel
  • 9.2 Distributors and Traders

10 Global Angioplasty Balloons Market Forecast by Regions, Countries, Manufacturers, Types and End Users

  • 10.1 Global Sales Volume and Revenue Forecast of Angioplasty Balloons by Regions (2024-2029)
  • 10.2 Global Sales Volume and Revenue Forecast of Angioplasty Balloons by Types (2024-2029)
  • 10.3 Global Sales Volume and Revenue Forecast of Angioplasty Balloons by End Users (2024-2029)
  • 10.4 Global Revenue Forecast of Angioplasty Balloons by Countries (2024-2029)
    • 10.4.1 United States Revenue Forecast (2024-2029)
    • 10.4.2 Canada Revenue Forecast (2024-2029)
    • 10.4.3 Germany Revenue Forecast (2024-2029)
    • 10.4.4 France Revenue Forecast (2024-2029)
    • 10.4.5 UK Revenue Forecast (2024-2029)
    • 10.4.6 Italy Revenue Forecast (2024-2029)
    • 10.4.7 Russia Revenue Forecast (2024-2029)
    • 10.4.8 Spain Revenue Forecast (2024-2029)
    • 10.4.9 Netherlands Revenue Forecast (2024-2029)
    • 10.4.10 China Revenue Forecast (2024-2029)
    • 10.4.11 Japan Revenue Forecast (2024-2029)
    • 10.4.12 Korea Revenue Forecast (2024-2029)
    • 10.4.13 India Revenue Forecast (2024-2029)
    • 10.4.14 Australia Revenue Forecast (2024-2029)
    • 10.4.15 Indonesia Revenue Forecast (2024-2029)
    • 10.4.16 Vietnam Revenue Forecast (2024-2029)
    • 10.4.17 Brazil Revenue Forecast (2024-2029)
    • 10.4.18 Mexico Revenue Forecast (2024-2029)
    • 10.4.19 Argentina Revenue Forecast (2024-2029)
    • 10.4.20 Colombia Revenue Forecast (2024-2029)
    • 10.4.21 Turkey Revenue Forecast (2024-2029)
    • 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
    • 10.4.23 South Africa Revenue Forecast (2024-2029)
    • 10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Angioplasty Balloons

  • 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Angioplasty Balloons
    • 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Angioplasty Balloons
    • 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Angioplasty Balloons
  • 11.2 Downstream Major Consumers Analysis of Angioplasty Balloons
  • 11.3 Major Suppliers of Angioplasty Balloons with Contact Information
  • 11.4 Supply Chain Relationship Analysis of Angioplasty Balloons

12 Angioplasty Balloons New Project Investment Feasibility Analysis

  • 12.1 Angioplasty Balloons New Project SWOT Analysis
  • 12.2 Angioplasty Balloons New Project Investment Feasibility Analysis
    • 12.2.1 Project Name
    • 12.2.2 Investment Budget
    • 12.2.3 Project Product Solutions
    • 12.2.4 Project Schedule

13 Angioplasty Balloons Research Findings and Conclusion

    14 Appendix

    • 14.1 Research Methodology
    • 14.2 References and Data Sources
      • 14.2.1 Primary Sources
      • 14.2.2 Secondary Paid Sources
      • 14.2.3 Secondary Public Sources
    • 14.3 Abbreviations and Units of Measurement
    • 14.4 Author Details

    The Angioplasty Balloons industry plays a crucial role in the field of interventional cardiology by offering a minimally invasive treatment option for patients with cardiovascular conditions. Angioplasty balloons are medical devices used to treat narrowed or blocked arteries, restoring blood flow and improving patients' quality of life. These balloons are primarily used in Ambulatory Surgery Centers (ASCs), Hospitals, and Catheterization Laboratories (Cath Lab) for performing angioplasty procedures.

    The global market size of Angioplasty Balloons is projected to reach US$2679 million in 2022, with a compound annual growth rate (CAGR) of 3.4%. This steady growth indicates a positive market trend and an increasing demand for these devices worldwide.

    There are several major global manufacturers in the Angioplasty Balloons industry, including Abbott Laboratories, Boston Scientific, C. R. Bard, Medtronic, Aachen Resonance, Acrostak, AMG International, Angioslide, Arthesys, Asahi Intecc, Atrium Medical, BrosMed, Cook Medical, Gadelius Medical, and Lepu Medical. These manufacturers have established market positions and a strong reputation for delivering high-quality products that meet the stringent regulatory requirements.

    The use of Angioplasty Balloons offers significant advantages over traditional open-heart surgeries, such as shorter recovery times, reduced hospital stays, and fewer complications. These factors contribute to the growing preference for minimally invasive procedures among patients and healthcare providers alike, driving the demand for angioplasty balloons.

    Furthermore, technological advancements in the design of angioplasty balloons have improved their performance and patient outcomes. Innovative features, such as increased balloon flexibility, enhanced trackability, and advanced coating materials, allow for precise positioning within the arterial system and better treatment results. These advancements, coupled with ongoing research and development efforts, present opportunities for further market growth and product innovation.

    While the industry shows promising prospects, there are also challenges to be addressed. The Angioplasty Balloons industry faces competition from alternative treatment options and devices, such as drug-eluting stents and bioresorbable vascular scaffolds. Manufacturers need to continually innovate and demonstrate the advantages of angioplasty balloons in order to maintain market share.

    Additionally, cost constraints within healthcare systems and reimbursement policies may impact the purchasing power and willingness of hospitals and medical facilities to invest in high-end angioplasty balloons. Manufacturers need to balance cost-effectiveness while ensuring product quality and efficacy to meet the demands of the market.

    In conclusion, the Angioplasty Balloons industry is experiencing steady growth, driven by the increasing demand for minimally invasive procedures and technological advancements. With a projected global market size of US$2679 million in 2022 and a compound annual growth rate of 3.4%, the industry offers significant opportunities for manufacturers and stakeholders. However, the industry must navigate challenges such as competition from alternative treatment options and cost constraints. By focusing on innovation, product quality, and cost-effectiveness, the Angioplasty Balloons industry can continue to thrive and contribute to improved patient outcomes in interventional cardiology.

    The SWOT analysis of the Angioplasty Balloons industry is as follows:

    Strengths:
    Effective Treatment Method: Angioplasty balloons provide an effective treatment option for patients with narrowed or blocked arteries. They can improve blood flow and alleviate symptoms, reducing the need for more invasive surgical procedures.
    Growing Market Size: The global angioplasty balloons market is projected to reach a size of US$2679 million in 2022 with a compound annual growth rate (CAGR) of 3.4%. This indicates a positive market trend and increasing demand for these devices.
    Technological Innovations: The industry benefits from ongoing technological advancements aimed at improving the performance and efficacy of angioplasty balloons. These innovations enhance procedural outcomes and patient safety, contributing to the industry's growth.

    Weaknesses:
    Market Competition: The angioplasty balloons industry faces competition from alternative treatment options and devices such as drug-eluting stents or bioresorbable vascular scaffolds. Manufacturers must differentiate their products and highlight the advantages of angioplasty balloons to maintain market share.
    Cost Considerations: The cost-effectiveness of angioplasty balloons could be a challenge for some healthcare systems and facilities, impacting their willingness to invest in these devices. Manufacturers need to address cost concerns and demonstrate the long-term benefits and value of their products.

    Opportunities:
    Increasing Prevalence of Cardiovascular Diseases: The rising global burden of cardiovascular diseases presents an opportunity for the angioplasty balloons industry. As the incidence of conditions like coronary artery disease continues to increase, the demand for minimally invasive treatment options such as angioplasty balloons is expected to grow.
    Technological Advancements: Ongoing research and development efforts can create opportunities for further technological advancements in angioplasty balloons. Innovations in balloon design, materials, and coatings can further improve device performance, patient outcomes, and expand the potential patient population.
    Emerging Markets: There is potential for market expansion in emerging economies that are experiencing increased healthcare spending and infrastructure development. These markets present an opportunity for manufacturers to tap into new customer bases and expand their global footprint.

    Threats:
    Regulatory Compliance: The angioplasty balloons industry is subject to strict regulatory requirements and standards to ensure patient safety. Compliance with these regulations can be challenging for manufacturers, requiring significant investments in research, development, and certification processes.
    Alternative Treatment Options: Angioplasty balloons face competition from alternative treatment options, including surgical procedures or other minimally invasive devices. Manufacturers need to continuously innovate and demonstrate the advantages of angioplasty balloons to maintain their market position.
    Reimbursement Policies: Reimbursement policies vary across different regions and healthcare systems, affecting the adoption and utilization of angioplasty balloons. Manufacturers need to navigate reimbursement challenges to ensure proper market access and availability.

    Key players in global Angioplasty Balloons market include:
    Abbott Laboratories
    Boston Scientific
    C. R. Bard
    Medtronic
    Aachen Resonance
    Acrostak
    AMG International
    Angioslide
    Arthesys
    Asahi Intecc
    Atrium Medical
    BrosMed
    Cook Medical
    Gadelius Medical
    Lepu Medical

    Market segmentation, by product types:
    Normal Balloon Catheter
    DEB Catheter
    Cutting Balloon Catheter
    Scoring Balloon Catheter

    Market segmentation, by applications:
    Ambulatory Surgery Centers (ASCs)
    Hospitals
    Catheterization Laboratories (Cath Lab)

    Buy now